Donoghue Forlines’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-28,509
Closed -$2.43M 126
2026
Q1
$2.43M Buy
+28,509
New +$2.54M 0.67% 50
2024
Q2
Sell
-5,977
Closed -$538K 229
2024
Q1
$538K Buy
5,977
+1,392
+30% +$118K 0.15% 155
2023
Q4
$365K Sell
4,585
-541
-11% -$40.7K 0.11% 181
2023
Q3
$365K Sell
5,126
-1,423
-22% -$106K 0.13% 179
2023
Q2
$505K Buy
+6,549
New +$507K 0.16% 125
2022
Q4
Sell
-5,104
Closed -$359K 231
2022
Q3
$359K Sell
5,104
-7,118
-58% -$558K 0.13% 152
2022
Q2
$979K Buy
12,222
+2,538
+26% +$198K 0.26% 95
2022
Q1
$734K Buy
+9,684
New +$767K 0.16% 213

Other funds holding CL

Donoghue Forlines's CL Position: Q2 2026 in Review

Donoghue Forlines sold out of Colgate-Palmolive (CL) in Q2 2026, closing a stake of 28,509 shares — an estimated $2.43M sold.

Donoghue Forlines first reported a position in CL in Q1 2022 and held it in 8 quarters. The position peaked at $2.43M in Q1 2026. 2,020 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Donoghue Forlines reported no remaining Colgate-Palmolive position as of Q2 2026 after selling out during the quarter.
  • Donoghue Forlines sold 28,509 Colgate-Palmolive shares in Q2 2026, an estimated $2.43M.
  • Donoghue Forlines first reported a position in Colgate-Palmolive in Q1 2022 and held it in 8 quarters.
  • Donoghue Forlines's Colgate-Palmolive position peaked at $2.43M in Q1 2026.
  • 2,020 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Donoghue Forlines's 13F filing for Q2 2026, filed 7 Aug 2026.